SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors
- 1 January 1996
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 103 (1-2) , 17-30
- https://doi.org/10.1007/bf01292613
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Localization and function of dopamine in the adult vertebrate retinaNeurochemistry International, 1992
- Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brainTrends in Pharmacological Sciences, 1989
- Biochemical, behavioural, and endocrine effects of CK 204-933, a novel 8?-ergoleneJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- New directions in neurotransmitter action: dopamine provides some important cluesTrends in Neurosciences, 1987
- Identification of Dopamine "D3'' and "D4'' Binding Sites, Labelled with [3H]2-Amino-6,7-Dihydroxy- 1,2,3,4- Tetrahydronaphthalene, as High Agonist Affinity States of the D1 and D2 Dopamine Receptors, RespectivelyJournal of Neurochemistry, 1986
- [3H]205-501, a Non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Multiple receptors for dopamineNature, 1979
- Neurochemical and Neuropharmacological Investigations with Four Ergot Derivatives: Bromocriptine, Dihydroergotoxine, CF 25-397 and CM 29-712Pharmacology, 1978
- A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissuesLife Sciences, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973